In the face of high competition, the Dutch company Royal Philips Electronics NV (NYSE:PHG) got approval from the U.S. Food and Drug Administration (FDA) to sell a combination scanner that performs both positron emission tomography (PET) and magnetic resonance imaging. The scanner is expected to accelerate imaging time for cancer patients, as PET identifies cancer cells as it absorbs chemical tracers.
The magnetic resonance imaging will be helpful to identify the surrounding tissue. In addition, … [visit site to read more] or compare Credit Card Rewards and Best Credit Cards
Nasdaq quotes delayed at least 15 minutes, all others at least 20 minutes.
Markets are closed on certain holidays. Stock Market Holiday List
By accessing this page, you agree to the following
Press Release Service provided by PRConnect.
Stock quotes supplied by Telekurs USA
Postage Rates Bots go here